imipenem, anhydrous has been researched along with Community Acquired Infection in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (17.24) | 18.2507 |
| 2000's | 11 (37.93) | 29.6817 |
| 2010's | 12 (41.38) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Adeleye, AI; Ajayi, A; Akinpelu, S; Smith, SI | 1 |
| Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Bhattacharjee, A; Deshamukhya, C; Gajamer, VR; Paul, D; Pradhan, N; Singh, AK; Tiwari, HK | 1 |
| Badal, RE; Cao, B; Chen, M; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Y; Hu, Z; Huang, W; Kong, H; Liao, K; Lu, J; Ni, Y; Shao, H; Shen, D; Su, J; Sun, Z; Wang, H; Wang, Y; Wu, A; Xu, Y; Yang, Q; Ye, H; Yu, Y; Zhang, H; Zhang, S | 1 |
| Han, J; Jung, JT; Kim, EY; Kim, HG; Kim, TW; Kwon, HH; Kwon, JG; Kwon, JS; Oh, JH | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Ariza-Prota, MA; Budiño, T; Casan, P; Fole-Vázquez, D; García-Clemente, M; Pando-Sandoval, A | 1 |
| Badal, RE; Hackel, MA; Lob, SH; Sahm, DF | 1 |
| Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
| Cizmeci, Z; Dereli, N; Günay, E; Küçükbayrak, A; Uğurman, F | 1 |
| Chin, K; Haruna, A; Ichiyama, S; Ito, I; Kadowaki, S; Kase, M; Matsumoto, H; Mishima, M; Nakai, A; Niimi, A; Tanabe, N; Tsukino, M; Yasutomo, Y | 1 |
| Gonzalez, F; Li, X; Mu, D; Tang, J; Wang, H; Xiong, Y | 1 |
| Chiba, K; Matsumoto, T; Nakamura, I; Yamaguchi, T | 1 |
| Balla, G; Bene, Z; Gaspar, I; Nagy, B; Papp, A; Voko, Z | 1 |
| Cravarezza, P; Donati, P; Franchino, L; Grassi, V; Pozzi, A; Prometti, P; Ravizzola, G; Romanelli, G; Zulli, R | 1 |
| Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W | 1 |
| Caillon, J; Christophe Roze, J; Denizot, S; Godon, N; Gras-Le Guen, C; Podevin, G; Potel, G | 1 |
| Fukuda, Y; Higashiyama, Y; Hirakata, Y; Izumikawa, K; Kohno, S; Miyazaki, Y; Mizuta, Y; Seki, M; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
| Ikonomidis, A; Markou, F; Poulou, A; Pournaras, S; Spanakis, N; Tsakris, A | 1 |
| Melzer, M; Petersen, I | 1 |
| Eller, J; Hamacher, J; Lode, H; Schaberg, T | 1 |
| Carretero, J; Carrión, F; Escoms, R; Pedro, MV; Prat, J | 1 |
| Chan, CH; Chan, TH; Ho, A; Lai, CK; Leung, R | 1 |
| Carlier, E; Govaerts, D; Jacobs, O; Lejeune, P; Piagnerelli, M | 1 |
| Atzeni, R; Bartoloni, A; Buonomini, MI; Corti, G; De Vizzi, GB; Fogliani, V; Franchino, L; Giura, R; Mancini, P; Moretti, AM; Paradisi, F; Petraglia, A; Romanelli, G; Strohmeyer, M | 1 |
2 review(s) available for imipenem, anhydrous and Community Acquired Infection
| Article | Year |
|---|---|
Appropriate use of the carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections | 2004 |
Changing role of carbapenems in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cilastatin; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Respiratory Tract Infections; Thienamycins | 1995 |
6 trial(s) available for imipenem, anhydrous and Community Acquired Infection
| Article | Year |
|---|---|
Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cilastatin; Community-Acquired Infections; Drug Combinations; Female; Humans; Imipenem; Injections, Intravenous; Male; Nursing Homes; Penicillanic Acid; Piperacillin; Pneumonia, Aspiration; Prospective Studies; Protease Inhibitors; Tazobactam; Treatment Outcome | 2010 |
Efficacy of methylprednisolone in children with severe community acquired pneumonia.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; C-Reactive Protein; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Length of Stay; Leukocyte Count; Male; Methylprednisolone; Pneumonia; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Community-Acquired Infections; Costs and Cost Analysis; Drug Combinations; Drug Costs; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Male; Meropenem; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome | 2002 |
Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Cilastatin; Community-Acquired Infections; Drug Combinations; Female; Humans; Imipenem; Male; Pneumonia, Bacterial; Prospective Studies; Protease Inhibitors; Severity of Illness Index; Sulbactam; Treatment Outcome | 2006 |
Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Cilastatin; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Hong Kong; Hospitalization; Humans; Imipenem; Injections, Intravenous; Male; Pneumonia, Bacterial; Protease Inhibitors; Survival Rate; Thienamycins | 1997 |
Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Community-Acquired Infections; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Safety; Thienamycins | 1999 |
21 other study(ies) available for imipenem, anhydrous and Community Acquired Infection
| Article | Year |
|---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cells, Cultured; Community-Acquired Infections; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Imipenem; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Nigeria; Ofloxacin; Tertiary Care Centers | 2020 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Escherichia coli encoding bla
Topics: Adult; beta-Lactamases; Community-Acquired Infections; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Imipenem; India; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Plasmids; Urinary Tract Infections; Young Adult | 2018 |
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China.
Topics: Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence | 2013 |
Changes in causative pathogens of acute cholangitis and their antimicrobial susceptibility over a period of 6 years.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cholangitis; Citrobacter freundii; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Imipenem; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Time Factors | 2014 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
Community-acquired bacteremic Streptomyces atratus pneumonia in animmunocompetent adult: a case report.
Topics: Actinomycetales Infections; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Community-Acquired Infections; Humans; Imipenem; Immunocompetence; Levofloxacin; Male; Pneumonia, Bacterial; Sequence Analysis, DNA; Streptomyces; Treatment Outcome | 2015 |
Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014.
Topics: Adolescent; Amikacin; Appendicitis; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Europe; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Male; Microbial Sensitivity Tests | 2017 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
[A community acquired pneumonia case caused by Ralstonia pickettii].
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Community-Acquired Infections; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Opportunistic Infections; Pneumonia, Bacterial; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Ralstonia pickettii; Treatment Outcome | 2009 |
Neonatal community-acquired pneumonia: pathogens and treatment.
Topics: Anti-Bacterial Agents; China; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Sputum; Thienamycins; Vancomycin | 2010 |
Epidemiological and microbiological analysis of community-associated methicillin-resistant Staphylococcus aureus strains isolated from a Japanese hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Child; Child, Preschool; Community-Acquired Infections; Exotoxins; Female; Genes, Bacterial; Genotype; Hospitals; Humans; Imipenem; Infant; Infant, Newborn; Leukocidins; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Staphylococcal Infections; Tokyo; Young Adult | 2012 |
Effectiveness of linezolid and imipenem association in the treatment of severe community-acquired pneumonia in children: two case reports.
Topics: Acetamides; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Safety; Treatment Outcome | 2006 |
Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Conjugation, Genetic; Drug Resistance, Bacterial; Greece; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Urinary Tract Infections | 2007 |
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Bile Duct Diseases; Community-Acquired Infections; Cross Infection; Drug Resistance; England; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Odds Ratio; Prospective Studies; Urinary Tract Infections | 2007 |
[Pleural empyema caused by Corynebacterium sp].
Topics: Aged; Clindamycin; Community-Acquired Infections; Corynebacterium Infections; Drainage; Empyema, Pleural; Humans; Imipenem; Male; Pneumonia; Thoracic Duct | 1995 |
Successful treatment of severe Legionella pneumonia with imipenem.
Topics: Community-Acquired Infections; Humans; Imipenem; Legionnaires' Disease; Male; Middle Aged; Thienamycins | 1999 |